Who
Jacqueline Elizabeth Shea
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Inovio Pharmaceuticals.
In numbers
- Trades disclosed
- 117
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $1.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Mar 2019
- Last trade
- 20 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 21 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —28,296 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $15K12,306 at $1.23 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —28,296 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —28,296 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —123,760 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,240 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —123,760 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,240 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —28,296 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $15K12,306 at $1.23 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —17,744 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $10K7,717 at $1.30 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —17,744 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —17,744 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —17,744 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $10K7,717 at $1.30 | filing |
| 4 Mar 2026filed 5 Mar 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —97,240 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —78,760 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —97,240 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —78,760 at $0.00 | filing |
News
Critical Analysis: Pyxis Oncology (NASDAQ:PYXS) versus Inovio Pharmaceuticals (NASDAQ:INO)INO · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Jacqueline Elizabeth Shea; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.